Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Koomen

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Clinical Chemistry|June 19, 2014
Immunoglobulins: expanding the role for mass spectrometry in protein biomarker quantificationJohn M Koomen
Analytical Chemistry|February 2, 2012
Evaluation of direct infusion-multiple reaction monitoring mass spectrometry for quantification of heat shock proteinsYun Xiang, John M Koomen
The Journal of Applied Laboratory Medicine|September 10, 2025
Evaluation of Proteinuria in Plasma Cell Disorders: Shortcomings of Measurements Based on 24-Hour Collections and Alternative ApproachesGlen L Hortin, John M Koomen
Oncotarget|April 21, 2011
Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanomaJohn M Koomen, Keiran S M Smalley
Journal of Mass Spectrometry : JMS|February 24, 2012
Evaluation of protein quantification using standard peptides containing single conservative amino acid replacementsElizabeth R Remily-Wood, John M Koomen
Journal of the American Society for Mass Spectrometry|August 15, 2009
Acid hydrolysis of proteins in matrix assisted laser desorption ionization matricesElizabeth Remily-Wood, Hayley Dirscherl, John M Koomen
Proteomics|November 23, 2011
A mass spectrometry-based method to screen for α-amidated peptidesZhenming An, Yudan Chen, John M Koomen, et al.
Cancer Informatics|May 21, 2009
Parametric power spectral density analysis of noise from instrumentation in MALDI TOF mass spectrometryHyunjin Shin, Miray Mutlu, John M Koomen, et al.
Cancer Research|November 17, 2005
Identification of an inactivating cysteine switch in protein kinase Cepsilon, a rational target for the design of protein kinase Cepsilon-inhibitory cancer therapeuticsFeng Chu, John M Koomen, Ryuji Kobayashi, et al.
Nature Structural & Molecular Biology|August 14, 2012
H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genesKiran Mahajan, Bin Fang, John M Koomen, et al.
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Clinical Chemistry|June 19, 2014
Immunoglobulins: expanding the role for mass spectrometry in protein biomarker quantificationJohn M Koomen
Analytical Chemistry|February 2, 2012
Evaluation of direct infusion-multiple reaction monitoring mass spectrometry for quantification of heat shock proteinsYun Xiang, John M Koomen
The Journal of Applied Laboratory Medicine|September 10, 2025
Evaluation of Proteinuria in Plasma Cell Disorders: Shortcomings of Measurements Based on 24-Hour Collections and Alternative ApproachesGlen L Hortin, John M Koomen
Oncotarget|April 21, 2011
Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanomaJohn M Koomen, Keiran S M Smalley
Journal of Mass Spectrometry : JMS|February 24, 2012
Evaluation of protein quantification using standard peptides containing single conservative amino acid replacementsElizabeth R Remily-Wood, John M Koomen
Journal of the American Society for Mass Spectrometry|August 15, 2009
Acid hydrolysis of proteins in matrix assisted laser desorption ionization matricesElizabeth Remily-Wood, Hayley Dirscherl, John M Koomen
Proteomics|November 23, 2011
A mass spectrometry-based method to screen for α-amidated peptidesZhenming An, Yudan Chen, John M Koomen, et al.
Cancer Informatics|May 21, 2009
Parametric power spectral density analysis of noise from instrumentation in MALDI TOF mass spectrometryHyunjin Shin, Miray Mutlu, John M Koomen, et al.
Cancer Research|November 17, 2005
Identification of an inactivating cysteine switch in protein kinase Cepsilon, a rational target for the design of protein kinase Cepsilon-inhibitory cancer therapeuticsFeng Chu, John M Koomen, Ryuji Kobayashi, et al.
Nature Structural & Molecular Biology|August 14, 2012
H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genesKiran Mahajan, Bin Fang, John M Koomen, et al.
Pageof 17